William Norbury1, David N Herndon1,2, Jessica Tanksley1,2, Marc G Jeschke3, Celeste C Finnerty1,2,4. 1. 1 Shriners Hospitals for Children , Galveston, Texas. 2. 2 Department of Surgery, University of Texas Medical Branch , Galveston, Texas. 3. 3 Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Department of Surgery, Division of Plastic Surgery and Department of Immunology, University of Toronto , Toronto, Ontario, Canada . 4. 4 Institute for Translational Science and Sealy Center for Molecular Medicine, University of Texas Medical Branch , Galveston, Texas.
Abstract
BACKGROUND: Developments in critical care and surgical approaches to treating burn wounds, together with newer antimicrobial treatments, have significantly reduced the morbidity and mortality rates associated with this injury. METHODS: Review of the pertinent English-language literature. RESULTS: Several resistant organisms have emerged as the maleficent cause of invasive infection in burn patients, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, Pseudomonas, Acinetobacter, non-albicans Candida spp., and Aspergillus. Advances in antimicrobial therapies and the release of new classes of antibiotics have certainly added to the armamentarium of therapeutic resources for the clinician. CONCLUSION: Strict infection control measures, constant wound surveillance with regular sampling of tissues for quantitative culture, and early excision and wound closure remain the principal adjuncts to control of invasive infections in burn patients.
BACKGROUND: Developments in critical care and surgical approaches to treating burn wounds, together with newer antimicrobial treatments, have significantly reduced the morbidity and mortality rates associated with this injury. METHODS: Review of the pertinent English-language literature. RESULTS: Several resistant organisms have emerged as the maleficent cause of invasive infection in burn patients, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, Pseudomonas, Acinetobacter, non-albicans Candida spp., and Aspergillus. Advances in antimicrobial therapies and the release of new classes of antibiotics have certainly added to the armamentarium of therapeutic resources for the clinician. CONCLUSION: Strict infection control measures, constant wound surveillance with regular sampling of tissues for quantitative culture, and early excision and wound closure remain the principal adjuncts to control of invasive infections in burn patients.
Authors: Desmond D Mascarenhas; Amina El Ayadi; Michael Wetzel; Anesh Prasai; Randy Mifflin; Jayson Jay; David N Herndon; Celeste C Finnerty Journal: Int J Burns Trauma Date: 2016-11-30
Authors: Alanna R Condren; Lisa Juliane Kahl; Gabriela Boelter; George Kritikos; Manuel Banzhaf; Lars E P Dietrich; Laura M Sanchez Journal: ACS Infect Dis Date: 2020-01-03 Impact factor: 5.084
Authors: C Baier; R Ipaktchi; E Ebadi; H-O Rennekampff; H-M Just; P M Vogt; F-C Bange; K Suchodolski Journal: Ann Burns Fire Disasters Date: 2018-09-30
Authors: Anne M Lachiewicz; Christopher G Hauck; David J Weber; Bruce A Cairns; David van Duin Journal: Clin Infect Dis Date: 2017-11-29 Impact factor: 9.079